Cipla

₹1403.9 4.6 | 0.3%

WEBSITE BSE:500087 NSE : CIPLA LTD. 18 May, 12:50

Market Cap ₹113357 Cr.

Stock P/E 27.5

P/B 4.1

Current Price ₹1403.9

Book Value ₹ 346.4

Face Value 2

52W High ₹1519

Dividend Yield 0.93%

52W Low ₹ 913.2

Edit Ratio

Cipla Research see more...

Overview Inc. Year: 1935Industry: Pharmaceuticals & Drugs

Cipla Limited is an primarily India-based enterprise, usually engaged in the commercial enterprise of pharmaceuticals. The Company's segments consist of Pharmaceuticals and New ventures. The Pharmaceuticals segment is engaged in growing, manufacturing, promoting and distributing widespread or branded accepted medicines, in addition to Active Pharmaceutical Ingredients (API). The New ventures segment includes the operations of the Company, a customer healthcare, Biosimilars and distinctiveness enterprise. Its product portfolio spans complex generics, as well as drugs within the breathing, anti-retroviral, urology, cardiology, anti-infective and central nervous system (CNS). The Company's geographical segments include India, America, South Africa and Rest of the World. The Company has its community of manufacturing, buying and selling and different incidental operations in India and International markets. The Company has total of 46 manufacturing sites.

Cipla Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

Cipla Quarterly Results

#(Fig in Cr.)
Net Sales
Other Income
Total Income
Total Expenditure
Operating Profit
Interest
Depreciation
Exceptional Income / Expenses
Profit Before Tax
Provision for Tax
Profit After Tax
Adjustments
Profit After Adjustments
Adjusted Earnings Per Share

Cipla Profit & Loss

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Net Sales	8202	9457	10132	11951	10768	11390	12374	12659	11303	15381	15791
Other Income	229	280	148	280	130	335	578	914	230	667	465
Total Income	8432	9737	10280	12231	10898	11725	12952	13573	11533	16048	16255
Total Expenditure	6083	7467	8170	9897	9172	9194	9872	9973	8235	11670	12006
Operating Profit	2348	2270	2109	2334	1726	2530	3080	3600	3298	4378	4249
Interest	33	128	136	147	39	12	17	36	45	27	27
Depreciation	303	324	433	443	500	530	570	600	469	547	596
Exceptional Income / Expenses	0	0	0	0	0	-78	0	0	0	0	-186
Profit Before Tax	2012	1818	1540	1744	1187	1911	2493	2964	2784	3804	3441
Provision for Tax	505	430	359	282	212	443	604	646	739	922	971
Profit After Tax	1507	1388	1181	1462	975	1469	1888	2318	2045	2883	2470
Adjustments	0	0	0	0	0	0	0	0	424	75	44
Profit After Adjustments	1507	1388	1181	1462	975	1469	1888	2318	2468	2958	2513
Adjusted Earnings Per Share	18.8	17.3	14.7	18.2	12.1	18.2	23.4	28.8	25.4	35.7	30.6

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	3%	8%	7%	7%
Operating Profit CAGR	-3%	6%	11%	6%
PAT CAGR	-14%	2%	11%	5%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	54%	17%	20%	14%
ROE Average	10%	12%	12%	13%
ROCE Average	15%	16%	17%	16%

Cipla Balance Sheet

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Shareholder's Funds	8870	10092	11090	11986	12801	14114	15782	17403	19928	22514	24638
Minority's Interest	0	0	0	0	0	0	0	0	0	0	0
Borrowings	1	0	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	1022	1706	2145	299	191	203	269	383	344	276	259
Total Current Liabilities	2265	2417	3566	2954	2556	2732	2368	2619	2692	2632	2700
Total Liabilities	12157	14215	16802	15239	15548	17048	18419	20406	22964	25449	27596
Fixed Assets	3418	3524	3594	3826	4235	4320	4127	4025	3943	3847	3747
Other Non-Current Assets	1963	5593	6650	4946	4967	4790	4813	7354	8829	10169	10478
Total Current Assets	6775	5098	6559	6467	6345	7938	9477	9025	10191	11335	13371
Total Assets	12157	14215	16802	15239	15548	17048	18419	20406	22964	25449	27596

Cipla Cash Flow

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Opening Cash & Cash Equivalents	55	105	46	64	40	45	217	64	262	295	177
Cash Flow from Operating Activities	1381	1812	1051	1728	2207	1117	1468	2018	3460	2773	3035
Cash Flow from Investing Activities	-2064	-1467	-1194	-1206	-1191	-592	-1147	-1126	-3360	-2464	-2758
Cash Flow from Financing Activities	733	-404	180	-547	-1011	-351	-473	-694	-66	-427	-425
Net Cash Inflow / Outflow	50	-59	37	-24	5	173	-152	198	34	-117	-148
Closing Cash & Cash Equivalent	105	46	83	40	45	217	64	262	295	177	29

Cipla Ratios

#	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Earnings Per Share (Rs)	18.77	17.29	14.71	18.2	12.12	18.24	23.44	28.75	25.35	35.73	30.6
CEPS(Rs)	22.55	21.32	20.1	23.71	18.33	24.82	30.51	36.19	31.16	42.5	37.98
DPS(Rs)	2	2	2	2	2	3	3	4	5	5	8.5
Book NAV/Share(Rs)	110.36	125.31	137.12	148.08	158.37	174.63	195.35	215.43	246.66	278.59	304.76
Core EBITDA Margin(%)	25.55	20.82	19.18	16.95	14.55	19.18	19.18	19.82	25.21	22.77	22.93
EBIT Margin(%)	24.66	20.37	16.39	15.61	11.17	16.8	19.24	22.13	23.25	23.51	21.01
Pre Tax Margin(%)	24.26	19.03	15.06	14.39	10.82	16.7	19.11	21.87	22.88	23.34	20.85
PAT Margin (%)	18.17	14.53	11.55	12.07	8.88	12.83	14.48	17.1	16.8	17.69	14.96
Cash Profit Margin (%)	21.82	17.91	15.79	15.72	13.44	17.46	18.85	21.53	20.66	21.04	18.57
ROA(%)	13.92	10.53	7.62	9.13	6.33	9.01	10.65	11.94	9.43	11.91	9.31
ROE(%)	18.38	14.67	11.21	12.77	7.91	10.96	12.67	14	10.97	13.61	10.49
ROCE(%)	23.53	18.73	14.31	14.79	9.34	14.03	16.69	18.08	15.15	18.05	14.71
Receivable days	69.63	64.42	67.48	59.47	63.78	68.17	77.02	90.59	98.93	65.28	62.84
Inventory Days	91.7	92.71	103.53	93.49	92.66	90.76	82.64	79.3	91.6	73.59	74.79
Payable days	115.08	112.48	133.27	109.33	128.04	160.5	156.18	169.73	184.38	117.14	132.39
PER(x)	20.23	22.19	48.35	28.14	48.88	29.78	22.58	14.71	32.16	28.51	29.44
Price/Book(x)	3.44	3.06	5.19	3.46	3.74	3.11	2.71	1.96	3.31	3.66	2.96
Dividend Yield(%)	0.53	0.52	0.28	0.39	0.34	0.55	0.57	0.95	0.61	0.49	0.94
EV/Net Sales(x)	3.82	3.35	5.76	3.53	4.45	3.84	3.43	2.65	5.74	5.25	4.54
EV/Core EBITDA(x)	13.35	13.94	27.69	18.1	27.76	17.26	13.79	9.33	19.67	18.44	16.88
Net Sales Growth(%)	17.56	15.29	7.14	17.95	-9.89	5.77	8.64	2.3	-10.72	36.08	2.66
EBIT Growth(%)	41.24	-4.84	-13.88	12.83	-35.16	56.86	30.49	19.55	-5.71	35.43	-9.49
PAT Growth(%)	34.09	-7.88	-14.93	23.81	-33.33	50.63	28.59	22.76	-11.8	40.98	-14.33
EPS Growth(%)	34.09	-7.88	-14.93	23.74	-33.42	50.51	28.5	22.67	-11.82	40.92	-14.37
Debt/Equity(x)	0.11	0.09	0.13	0.1	0.03	0.01	0	0	0	0	0
Current Ratio(x)	2.99	2.11	1.84	2.19	2.48	2.91	4	3.45	3.79	4.31	4.95
Quick Ratio(x)	1.99	1.09	0.93	1.2	1.44	1.79	2.79	2.29	2.64	2.98	3.74
Interest Cover(x)	61.27	15.22	12.32	12.86	31.28	161.62	147.9	83.23	62.77	142.27	128.33
Total Debt/Mcap(x)	0.03	0.03	0.02	0.03	0.01	0	0	0	0	0	0

Cipla Shareholding Pattern

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	35.92	33.42	33.42	33.41	33.41	33.41	33.4	33.4	33.4	33.4
FII	24.23	26.48	27.48	27.52	28.21	27.29	25.44	25.69	25.68	25.77
DII	21.42	21.87	21.22	21.56	20.96	21.96	24.22	24.06	24.22	24.3
Public	17.92	17.62	17.3	16.91	16.81	16.92	16.73	16.64	16.5	16.32
Others	0.52	0.61	0.59	0.6	0.61	0.42	0.2	0.21	0.21	0.21
Total	100	100	100	100	100	100	100	100	100	100

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	28.98	26.96	26.96	26.96	26.96	26.96	26.96	26.96	26.96	26.96
FII	19.55	21.36	22.17	22.21	22.77	22.03	20.54	20.74	20.73	20.81
DII	17.28	17.65	17.12	17.4	16.92	17.72	19.55	19.43	19.55	19.62
Public	14.46	14.22	13.96	13.65	13.57	13.66	13.51	13.43	13.32	13.18
Others	0.42	0.49	0.47	0.48	0.49	0.34	0.16	0.17	0.17	0.17
Total	80.68	80.68	80.69	80.7	80.71	80.72	80.72	80.73	80.74	80.74

Pros

Company is almost debt free.

Cons

Promoter holding is low: 33.4%.
Company has a low return on equity of 12% over the last 3 years.
Debtor days have increased from 117.14 to 132.39days.
Stock is trading at 4.1 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Cipla News

IPO

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Cipla

Add Watchlist

Cipla Research see more...

Overview Inc. Year: 1935Industry: Pharmaceuticals & Drugs

Cipla Share Price

Alert Data

Quarterly Price

Peer Comparison

Cipla Quarterly Results

Cipla Profit & Loss

Growth Rates

Cipla Balance Sheet

Cipla Cash Flow

Cipla Ratios

Cipla Shareholding Pattern

Cipla News

IPO

Stocx: India's #1 Marketplace to Find Your Winning Stock

Please Login!

Error!